首页 > 最新文献

Wake Forest law review最新文献

英文 中文
The Process of Managing Medical Malpractice Cases: The Role of Standard of Care 医疗事故案件处理过程:护理标准的作用
Pub Date : 2002-11-23 DOI: 10.2139/SSRN.347760
R. Peeples, C. Harris, Thomas B. Metzloff
In medical malpractice litigation, how the standard of care is determined is of obvious importance, since failure by a defendant-physician to meet the relevant standard of care constitutes negligence. Any effort to reform how standard-of-care determinations are made should start with an understanding of the entire claims resolution process. The usual image - that of opposing experts testifying at trial - is both incomplete and misleading. Most cases are either settled by the parties or abandoned by the plaintiff, short of trial. We reviewed insurers' closed claims files, representing a sample of medical malpractice lawsuits filed in North Carolina between 1991 and 1995, as well as the matching court files. As a result, we obtained unique and highly detailed information about these cases. In this Article we report on our findings, as they relate to the insurer's assessment of the standard of care. We conclude that a shift in standard-of-care determinations to a more empirical, scientifically-based inquiry would not be likely to change the dynamics of the settlement process, where the emphasis is on bargaining and negotiation, rather than on reaching conclusions about the standard of care.
在医疗事故诉讼中,如何确定护理标准显然很重要,因为被告医生未能达到相关的护理标准构成过失。任何改革医疗标准决定方式的努力都应该从理解整个索赔解决过程开始。通常的印象——对方专家在审判中作证——既不完整又具有误导性。大多数案件要么由当事人解决,要么由原告放弃,没有经过审判。我们审查了保险公司已结案的索赔档案,这些档案代表了1991年至1995年期间在北卡罗来纳州提起的医疗事故诉讼的样本,以及相应的法庭档案。因此,我们获得了关于这些病例的独特和非常详细的信息。在这篇文章中,我们报告了我们的发现,因为它们与保险公司对护理标准的评估有关。我们得出的结论是,将护理标准的确定转变为更经验的、基于科学的调查,不太可能改变解决过程的动态,因为解决过程的重点是讨价还价和谈判,而不是得出关于护理标准的结论。
{"title":"The Process of Managing Medical Malpractice Cases: The Role of Standard of Care","authors":"R. Peeples, C. Harris, Thomas B. Metzloff","doi":"10.2139/SSRN.347760","DOIUrl":"https://doi.org/10.2139/SSRN.347760","url":null,"abstract":"In medical malpractice litigation, how the standard of care is determined is of obvious importance, since failure by a defendant-physician to meet the relevant standard of care constitutes negligence. Any effort to reform how standard-of-care determinations are made should start with an understanding of the entire claims resolution process. The usual image - that of opposing experts testifying at trial - is both incomplete and misleading. Most cases are either settled by the parties or abandoned by the plaintiff, short of trial. We reviewed insurers' closed claims files, representing a sample of medical malpractice lawsuits filed in North Carolina between 1991 and 1995, as well as the matching court files. As a result, we obtained unique and highly detailed information about these cases. In this Article we report on our findings, as they relate to the insurer's assessment of the standard of care. We conclude that a shift in standard-of-care determinations to a more empirical, scientifically-based inquiry would not be likely to change the dynamics of the settlement process, where the emphasis is on bargaining and negotiation, rather than on reaching conclusions about the standard of care.","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"37 1","pages":"877"},"PeriodicalIF":0.0,"publicationDate":"2002-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68597353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Down for the count? State regulation of aborted fetal tissue research. 趴下计数?国家对流产胎儿组织研究的监管。
Pub Date : 2002-01-01
Rachel Keener
{"title":"Down for the count? State regulation of aborted fetal tissue research.","authors":"Rachel Keener","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"37 1","pages":"217-37"},"PeriodicalIF":0.0,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22328551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reinventing Tax Expenditure Reform: Improving Program Oversight Under the Government Performance and Results Act 重塑税收支出改革:根据《政府绩效与成果法》改进项目监督
Pub Date : 2001-03-21 DOI: 10.2139/SSRN.258973
M. L. Heen
This Article examines the Government Performance and Results Act framework for performance-based management and oversight of federally-funded programs, describes emerging efforts to incorporate tax expenditures into the performance review process, and places these developments into context by evaluating past experiences with tax expenditure reform. Government-wide performance-based management reforms provide a promising executive branch mechanism for achieving more coordinated review of functionally related government programs, whether funded or implemented through direct expenditures, tax expenditures, or regulatory programs. However, as past experience illustrates (including, for example, experience with employment subsidies such as the Work Opportunity Tax Credit and the Welfare-to-Work Tax Credit), significant institutional obstacles stand in the way of comprehensive reform. The Article ends with a discussion of the type of fundamental structural reforms that will be needed before meaningful legislative oversight of functionally related government programs can be achieved.
本文考察了《政府绩效与结果法》框架对联邦资助项目的绩效管理和监督,描述了将税收支出纳入绩效审查过程的新努力,并通过评估过去税收支出改革的经验将这些发展置于背景中。政府范围内基于绩效的管理改革提供了一种有希望的行政部门机制,可以对与职能相关的政府项目进行更协调的审查,无论是通过直接支出、税收支出还是监管项目资助或实施的。然而,正如过去的经验所表明的那样(例如,包括就业补贴的经验,如工作机会税收抵免和福利工作税收抵免),重大的制度障碍阻碍了全面改革。文章最后讨论了在对政府职能相关项目进行有意义的立法监督之前需要进行的基本结构改革的类型。
{"title":"Reinventing Tax Expenditure Reform: Improving Program Oversight Under the Government Performance and Results Act","authors":"M. L. Heen","doi":"10.2139/SSRN.258973","DOIUrl":"https://doi.org/10.2139/SSRN.258973","url":null,"abstract":"This Article examines the Government Performance and Results Act framework for performance-based management and oversight of federally-funded programs, describes emerging efforts to incorporate tax expenditures into the performance review process, and places these developments into context by evaluating past experiences with tax expenditure reform. Government-wide performance-based management reforms provide a promising executive branch mechanism for achieving more coordinated review of functionally related government programs, whether funded or implemented through direct expenditures, tax expenditures, or regulatory programs. However, as past experience illustrates (including, for example, experience with employment subsidies such as the Work Opportunity Tax Credit and the Welfare-to-Work Tax Credit), significant institutional obstacles stand in the way of comprehensive reform. The Article ends with a discussion of the type of fundamental structural reforms that will be needed before meaningful legislative oversight of functionally related government programs can be achieved.","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"35 1","pages":"751"},"PeriodicalIF":0.0,"publicationDate":"2001-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2139/SSRN.258973","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68213828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
DNA databanks: law enforcement's greatest surveillance tool? DNA数据库:执法部门最大的监控工具?
Pub Date : 1999-01-01
M Hibbert

All fifty states have laws requiring the collection of DNA samples from certain classes of criminals. Genetic profiles are gleaned from these samples and entered into DNA databanks, after which they then can be accessed by law enforcement personnel and others. DNA forensic technologies can be used to identify criminal offenders, but they can also be used in ways that reveal health and other personal information about the target and even about his or her relations. Moreover, the rapid introduction of ever-changing types of DNA forensic techniques creates a potential for error. Such errors may wrongly implicate some individuals for a crime and may wrongly exculpate others. This Article examines weaknesses in state DNA databanking laws regarding the protection of genetic privacy and imposition of quality assurance mechanisms and suggests policies which state legislatures should incorporate into the state DNA databanking scheme.

所有50个州都有法律要求收集特定类别罪犯的DNA样本。从这些样本中收集基因资料并输入DNA数据库,之后执法人员和其他人可以访问这些资料。DNA法医技术可用于识别罪犯,但也可用于揭示目标的健康和其他个人信息,甚至是他或她的关系。此外,不断变化的DNA法医技术的快速引入也带来了出错的可能性。这种错误可能错误地将某些人与犯罪联系起来,而可能错误地为其他人开脱罪名。本文探讨了州DNA数据库法律在保护基因隐私和强制实施质量保证机制方面的弱点,并提出了州立法机构应纳入州DNA数据库计划的政策建议。
{"title":"DNA databanks: law enforcement's greatest surveillance tool?","authors":"M Hibbert","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>All fifty states have laws requiring the collection of DNA samples from certain classes of criminals. Genetic profiles are gleaned from these samples and entered into DNA databanks, after which they then can be accessed by law enforcement personnel and others. DNA forensic technologies can be used to identify criminal offenders, but they can also be used in ways that reveal health and other personal information about the target and even about his or her relations. Moreover, the rapid introduction of ever-changing types of DNA forensic techniques creates a potential for error. Such errors may wrongly implicate some individuals for a crime and may wrongly exculpate others. This Article examines weaknesses in state DNA databanking laws regarding the protection of genetic privacy and imposition of quality assurance mechanisms and suggests policies which state legislatures should incorporate into the state DNA databanking scheme.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"767-825"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22312932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breaking the stalemate: a prospective regulatory framework for unforseen research uses of human tissue samples and health information. 打破僵局:对人体组织样本和健康信息的不可预见的研究使用的前瞻性监管框架。
Pub Date : 1999-01-01
H T Greely

The legal and ethical issues raised by new research uses of previously collected human tissues and health information are increasingly important to genetics research. This Article discusses and criticizes current positions on such uses, including the recent report of the National Bioethics Advisory Commission, Research Involving Human Biological Materials. It then proposes a new regulatory framework for tissue and information collected in the future that would better protect the interests of the people who provide them. It ends by suggesting a resolution for the problems of previously collected tissue and information.

利用以前收集的人体组织和健康信息进行新的研究所引起的法律和伦理问题对遗传学研究越来越重要。这篇文章讨论并批评了目前对这些用途的立场,包括国家生物伦理咨询委员会最近的报告《涉及人类生物材料的研究》。然后,它为未来收集的组织和信息提出了一个新的监管框架,以更好地保护提供这些组织和信息的人的利益。它最后提出了解决先前收集的组织和信息问题的方法。
{"title":"Breaking the stalemate: a prospective regulatory framework for unforseen research uses of human tissue samples and health information.","authors":"H T Greely","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The legal and ethical issues raised by new research uses of previously collected human tissues and health information are increasingly important to genetics research. This Article discusses and criticizes current positions on such uses, including the recent report of the National Bioethics Advisory Commission, Research Involving Human Biological Materials. It then proposes a new regulatory framework for tissue and information collected in the future that would better protect the interests of the people who provide them. It ends by suggesting a resolution for the problems of previously collected tissue and information.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"737-66"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22314244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of genetic enhancement on equality. 基因增强对平等的影响。
Pub Date : 1999-01-01
M H Shapiro

There apparently is a genuine possibility that genetic and non-genetic mechanisms eventually will be able to significantly enhance human capabilities and traits generally. Examining this prospect from the standpoint of equality considerations is one useful way to inquire into the effects of such enhancement technologies. Because of the nature and limitations of competing ideas of equality, we are inevitably led to investigate a very broad range of issues. This Article considers matters of distribution and withholding of scarce enhancement resources and links different versions of equality to different modes of distribution. It briefly addresses the difficulties of defining "enhancement" and "trait" and links the idea of a "merit attribute" to that of a "resource attractor." The role of disorder-based justifications is related to equality considerations, as is the possibility of the reduction or "objectification" of persons arising from the use of enhancement resources. Risks of intensified and more entrenched forms of social stratification are outlined. The Article also considers whether the notion of merit can survive, and whether the stability of democratic institutions based on a one-person, one-vote standard is threatened by attitude shifts given the new technological prospects. It refers to John Stuart Mill's "plural voting" proposal to illustrate one challenge to equal-vote democracy.

显然,遗传和非遗传机制最终将能够显著增强人类的能力和特征,这是一种真正的可能性。从平等考虑的角度审视这一前景,是探讨此类增强技术效果的一个有用方法。由于相互竞争的平等观念的性质和局限性,我们不可避免地要调查范围非常广泛的问题。本文考虑了稀缺增强型资源的分配和保留问题,并将不同版本的平等与不同的分配方式联系起来。它简要地阐述了定义“增强”和“特质”的困难,并将“优点属性”的概念与“资源吸引者”的概念联系起来。基于混乱的理由的作用与平等方面的考虑有关,因为使用增强资源而可能减少或“客观化”人。概述了社会分层形式加剧和更加根深蒂固的危险。文章还考虑了择优观念是否能够继续存在,以及基于一人一票标准的民主制度的稳定性是否会受到新技术前景带来的态度转变的威胁。它指的是约翰•斯图尔特•密尔(John Stuart Mill)的“复数投票”提议,以说明对平等投票民主的一个挑战。
{"title":"The impact of genetic enhancement on equality.","authors":"M H Shapiro","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There apparently is a genuine possibility that genetic and non-genetic mechanisms eventually will be able to significantly enhance human capabilities and traits generally. Examining this prospect from the standpoint of equality considerations is one useful way to inquire into the effects of such enhancement technologies. Because of the nature and limitations of competing ideas of equality, we are inevitably led to investigate a very broad range of issues. This Article considers matters of distribution and withholding of scarce enhancement resources and links different versions of equality to different modes of distribution. It briefly addresses the difficulties of defining \"enhancement\" and \"trait\" and links the idea of a \"merit attribute\" to that of a \"resource attractor.\" The role of disorder-based justifications is related to equality considerations, as is the possibility of the reduction or \"objectification\" of persons arising from the use of enhancement resources. Risks of intensified and more entrenched forms of social stratification are outlined. The Article also considers whether the notion of merit can survive, and whether the stability of democratic institutions based on a one-person, one-vote standard is threatened by attitude shifts given the new technological prospects. It refers to John Stuart Mill's \"plural voting\" proposal to illustrate one challenge to equal-vote democracy.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"561-637"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22314357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Herd behavior in designer genes. 设计者基因中的群体行为。
Pub Date : 1999-01-01
P H Huang

The ability of individuals to choose their children's genes has increased over time and may ultimately culminate in a world involving free market reprogenetic technologies. Reprogenetic technologies combine advances in reproductive biology and genetics to provide humans increased control over their children's genes. This Article offers economic perspectives that are helpful in understanding the possibly unexpected ethical, legal, and social issues at stake in using reprogenetic technologies for trait enhancement selection. The Appendix analyzes two competitive games that might arise in such a biotechnological society. Specifically, the Article focuses on herd behavior, caused by either a popularity contest or positional competition, in the choice of genetic traits. The analytical game-theoretic models in the Appendix can have several equilibrium outcomes in terms of individual reprogenetic technological choices and corresponding beliefs about such choices by others. This multiplicity of potential social outcomes suggests that a society can attain efficiency if the state or some private organization transforms individual parents' beliefs over the choices of other parents regarding their children's traits and, thus, coordinates parental reprogenetic decisions by selecting, as focal, certain beliefs over parents' reprogenetic decisions.

个人选择子女基因的能力随着时间的推移而增强,并可能最终在一个涉及自由市场生殖技术的世界达到顶峰。生殖技术结合了生殖生物学和遗传学的进步,使人类能够更好地控制子女的基因。这篇文章提供了经济学的观点,有助于理解可能意想不到的伦理、法律和社会问题的风险,在使用生殖技术进行性状增强选择。附录分析了在这样一个生物技术社会中可能出现的两种竞争游戏。具体来说,本文关注的是在遗传性状的选择中,由人气竞争或位置竞争引起的羊群行为。附录中的分析博弈论模型可以在个体的生殖技术选择和他人对这种选择的相应信念方面有几个平衡结果。这种潜在社会结果的多样性表明,如果国家或一些私人组织改变了个体父母对其他父母对子女特征的选择的信念,从而通过选择父母的生殖决定作为焦点来协调父母的生殖决定,那么社会就可以获得效率。
{"title":"Herd behavior in designer genes.","authors":"P H Huang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The ability of individuals to choose their children's genes has increased over time and may ultimately culminate in a world involving free market reprogenetic technologies. Reprogenetic technologies combine advances in reproductive biology and genetics to provide humans increased control over their children's genes. This Article offers economic perspectives that are helpful in understanding the possibly unexpected ethical, legal, and social issues at stake in using reprogenetic technologies for trait enhancement selection. The Appendix analyzes two competitive games that might arise in such a biotechnological society. Specifically, the Article focuses on herd behavior, caused by either a popularity contest or positional competition, in the choice of genetic traits. The analytical game-theoretic models in the Appendix can have several equilibrium outcomes in terms of individual reprogenetic technological choices and corresponding beliefs about such choices by others. This multiplicity of potential social outcomes suggests that a society can attain efficiency if the state or some private organization transforms individual parents' beliefs over the choices of other parents regarding their children's traits and, thus, coordinates parental reprogenetic decisions by selecting, as focal, certain beliefs over parents' reprogenetic decisions.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"639-69"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22314358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic testing, genetic medicine, and managed care. 基因检测、基因医学和管理式医疗。
Pub Date : 1999-01-01
M A Rothstein, S Hoffman

As modern human genetics moves from the research setting to the clinical setting, it will encounter the managed care system. Issues of cost, access, and quality of care will affect the availability and nature of genetic testing, genetic counseling, and genetic therapies. This Article will explore such issues as professional education, coverage of genetic services, privacy and confidentiality, and liability. It will conclude with a series of recommendations for the practice of genetic medicine in the age of managed care.

随着现代人类遗传学从研究环境转移到临床环境,它将遇到管理护理系统。成本、获取和护理质量问题将影响基因检测、遗传咨询和遗传治疗的可得性和性质。本文将探讨专业教育、遗传服务的覆盖范围、隐私和保密以及责任等问题。最后,将对管理式医疗时代的遗传医学实践提出一系列建议。
{"title":"Genetic testing, genetic medicine, and managed care.","authors":"M A Rothstein,&nbsp;S Hoffman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As modern human genetics moves from the research setting to the clinical setting, it will encounter the managed care system. Issues of cost, access, and quality of care will affect the availability and nature of genetic testing, genetic counseling, and genetic therapies. This Article will explore such issues as professional education, coverage of genetic services, privacy and confidentiality, and liability. It will conclude with a series of recommendations for the practice of genetic medicine in the age of managed care.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"849-88"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22312933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How will we regulate genetic enhancement? 我们将如何监管基因增强?
Pub Date : 1999-01-01
M J Mehlman

Genetic enhancement technologies present difficult and novel regulatory issues, including the problem of measuring and comparing risks and benefits and dealing with the impact of these technologies on social values. This Article describes and evaluates the potential approaches that may be taken to regulate these technologies. The author concludes that a variety of approaches will be necessary, involving self-regulation, government restrictions on access and use, licensing, and a national lottery.

基因增强技术提出了困难和新的监管问题,包括衡量和比较风险和利益的问题,以及处理这些技术对社会价值的影响。本文描述并评估了可能用于规范这些技术的潜在方法。作者的结论是,有必要采取多种方法,包括自我监管、政府对获取和使用的限制、许可和国家彩票。
{"title":"How will we regulate genetic enhancement?","authors":"M J Mehlman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Genetic enhancement technologies present difficult and novel regulatory issues, including the problem of measuring and comparing risks and benefits and dealing with the impact of these technologies on social values. This Article describes and evaluates the potential approaches that may be taken to regulate these technologies. The author concludes that a variety of approaches will be necessary, involving self-regulation, government restrictions on access and use, licensing, and a national lottery.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"671-714"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22314242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic enhancement in the twenty-first century: three problems in legal imagining. 二十一世纪的基因增强:法律想象中的三个问题。
Pub Date : 1999-01-01
R M Berry

By what method should we resolve the ethical and public policy issues surrounding genetic enhancement: a utilitarian calculus, appeal to Scripture, application of neo-Kantian principles? In this Article, the author claims that, despite the diversity of our basic methodological commitments, we can advance our shared understanding of the issues surrounding genetic enhancement and come to agree upon certain central features as essential to any adequate method for resolving those issues. The author attempts to make modest headway on both fronts by engaging in "legal imagining." Legal imagining consists of examining hypothetical problems from the lawyer's perspective, the perspective of a caring, professional friend. This Article examines and discusses three problems in legal imagining.

我们应该用什么方法来解决围绕基因增强的伦理和公共政策问题:功利主义的计算,诉诸圣经,还是应用新康德主义的原则?在这篇文章中,作者声称,尽管我们的基本方法承诺的多样性,我们可以推进我们对围绕遗传增强的问题的共同理解,并就某些核心特征达成一致,这些特征对于解决这些问题的任何适当方法都是必不可少的。作者试图通过“法律想象”在这两个方面取得一定的进展。法律想象包括从律师的角度,从一个有爱心的专业朋友的角度来审视假设的问题。本文考察和讨论了法律想象中的三个问题。
{"title":"Genetic enhancement in the twenty-first century: three problems in legal imagining.","authors":"R M Berry","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>By what method should we resolve the ethical and public policy issues surrounding genetic enhancement: a utilitarian calculus, appeal to Scripture, application of neo-Kantian principles? In this Article, the author claims that, despite the diversity of our basic methodological commitments, we can advance our shared understanding of the issues surrounding genetic enhancement and come to agree upon certain central features as essential to any adequate method for resolving those issues. The author attempts to make modest headway on both fronts by engaging in \"legal imagining.\" Legal imagining consists of examining hypothetical problems from the lawyer's perspective, the perspective of a caring, professional friend. This Article examines and discusses three problems in legal imagining.</p>","PeriodicalId":83479,"journal":{"name":"Wake Forest law review","volume":"34 3","pages":"715-35"},"PeriodicalIF":0.0,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22314243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Wake Forest law review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1